Advertisement
AXGN vs TCMD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXGN is a Buy and TCMD is a Hold.
Momentum Indicator for AXGN turns positive, indicating new upward trend
AXGN saw its Momentum Indicator move above the 0 level on October 21, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned positive. In 70 of the 85 cases, the stock moved higher in the following days. The odds of a move higher are at 82%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for AXGN just turned positive on October 20, 2026. Looking at past instances where AXGN's MACD turned positive, the stock continued to rise in 38 of 47 cases over the following month. The odds of a continued upward trend are 81%.
AXGN moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +32.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXGN advanced for three days, in 267 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
AXGN broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AXGN entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.413) is normal, around the industry mean (4.204). P/E Ratio (-74.403) is within average values for comparable stocks, (1.723). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). AXGN has a moderately high Dividend Yield (0.080) as compared to the industry average of (0.010). P/S Ratio (8.961) is also within normal values, averaging (40.124).
The Tickeron Profit vs. Risk Rating rating for this company is 19 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron Seasonality Score of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. AXGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
TCMD in upward trend: 10-day moving average crossed above 50-day moving average on October 22, 2026
The 10-day moving average for TCMD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on TCMD as a result. In 77 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
TCMD moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where TCMD advanced for three days, in 210 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Aroon Indicator entered an Uptrend today. In 197 of 234 cases where TCMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 62 cases where TCMD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 66%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TCMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
TCMD broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. TCMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.314) is normal, around the industry mean (4.204). P/E Ratio (20.982) is within average values for comparable stocks, (1.723). Projected Growth (PEG Ratio) (0.290) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (1.458) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 69 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TCMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
AXGN | TCMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 36 | 27 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | 68 Overvalued | |
PROFIT vs RISK RATING 1..100 | 19 | 100 | |
SMR RATING 1..100 | 95 | 65 | |
PRICE GROWTH RATING 1..100 | 36 | 48 | |
P/E GROWTH RATING 1..100 | 77 | 69 | |
SEASONALITY SCORE 1..100 | 33 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AXGN's Valuation (5) in the Medical Specialties industry is somewhat better than the same rating for TCMD (68). This means that AXGN’s stock grew somewhat faster than TCMD’s over the last 12 months.
AXGN's Profit vs Risk Rating (19) in the Medical Specialties industry is significantly better than the same rating for TCMD (100). This means that AXGN’s stock grew significantly faster than TCMD’s over the last 12 months.
TCMD's SMR Rating (65) in the Medical Specialties industry is in the same range as AXGN (95). This means that TCMD’s stock grew similarly to AXGN’s over the last 12 months.
AXGN's Price Growth Rating (36) in the Medical Specialties industry is in the same range as TCMD (48). This means that AXGN’s stock grew similarly to TCMD’s over the last 12 months.
TCMD's P/E Growth Rating (69) in the Medical Specialties industry is in the same range as AXGN (77). This means that TCMD’s stock grew similarly to AXGN’s over the last 12 months.
| AXGN | TCMD | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 74% | N/A |
| Stochastic ODDS (%) | 1 day ago 73% | 1 day ago 66% |
| Momentum ODDS (%) | 1 day ago 82% | 1 day ago 79% |
| MACD ODDS (%) | 1 day ago 81% | N/A |
| TrendWeek ODDS (%) | 1 day ago 82% | 1 day ago 75% |
| TrendMonth ODDS (%) | 1 day ago 86% | 1 day ago 85% |
| Advances ODDS (%) | 5 days ago 82% | 5 days ago 78% |
| Declines ODDS (%) | 7 days ago 82% | 1 day ago 75% |
| BollingerBands ODDS (%) | 1 day ago 78% | 1 day ago 72% |
| Aroon ODDS (%) | 1 day ago 77% | 1 day ago 84% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AXGN’s FA Score shows that 2 FA rating(s) are green while TCMD’s FA Score has 0 green FA rating(s).
- AXGN’s FA Score: 2 green, 3 red.
- TCMD’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AXGN’s TA Score shows that 4 TA indicator(s) are bullish while TCMD’s TA Score has 5 bullish TA indicator(s).
- AXGN’s TA Score: 4 bullish, 5 bearish.
- TCMD’s TA Score: 5 bullish, 3 bearish.
Price Growth
AXGN (@Medical/Nursing Services) experienced а +31.12% price change this week, while TCMD (@Medical/Nursing Services) price change was -2.22% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.23%. For the same industry, the average monthly price growth was -8.25%, and the average quarterly price growth was -9.51%.
Reported Earning Dates
AXGN is expected to report earnings on Feb 23, 2027.
TCMD is expected to report earnings on Feb 23, 2027.
Industries' Descriptions
@Medical/Nursing Services (-1.23% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
AXGN and
Correlation & Price change
A.I.dvisor indicates that over the last year, AXGN has been loosely correlated with XRAY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if AXGN jumps, then XRAY could also see price increases.
| Ticker / NAME | Correlation To AXGN | 1D Price Change % | ||
|---|---|---|---|---|
| AXGN | 100% | +0.97% | ||
| XRAY - AXGN | 36% Loosely correlated | +3.88% | ||
| ITGR - AXGN | 31% Poorly correlated | -0.03% | ||
| CLPT - AXGN | 31% Poorly correlated | -6.75% | ||
| GMED - AXGN | 31% Poorly correlated | +1.81% | ||
| ICUI - AXGN | 30% Poorly correlated | -0.85% | ||
More | ||||
TCMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, TCMD has been loosely correlated with CSTL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TCMD jumps, then CSTL could also see price increases.
| Ticker / NAME | Correlation To TCMD | 1D Price Change % | ||
|---|---|---|---|---|
| TCMD | 100% | -0.74% | ||
| CSTL - TCMD | 50% Loosely correlated | -5.97% | ||
| UFPT - TCMD | 49% Loosely correlated | -0.19% | ||
| AORT - TCMD | 43% Loosely correlated | +4.43% | ||
| BVS - TCMD | 38% Loosely correlated | -1.31% | ||
| GH - TCMD | 38% Loosely correlated | -4.51% | ||
More | ||||